In this study zero, first and second order derivative spectrophotometric method were developed for the estimation of sitagliptine. In zero order spectrophotometery, absorbance value was measured at 267nm. In first derivative spectrophotometry amplitudes were measured at 213nm. In second derivative spectrophotometry amplitudes were measured at 276nm. Calibration curves were linear between the concentration range of 20-60µg/ml, 20-60µg/ml and 40-80µg/ml respectively. The % RSD value is less than 2% and the recovery were near 100% for all methods. This method has been validated for linearity, accuracy and precision and found to be rapid, precise, accurate and economical and can be applied for routine estimation of sitagliptine in solid dosage form. The validation of method was carried out utilizing ICH-guidelines.
INTRODUCTION
Sitagliptin phosphate monohydrate (SPM) chemically, (3R)-3-amino-1- [3-(trifluoromethyl)-5,6-dihydro[1,2,4] triazolo [4, 3-a] pyrazin -7 (8H) -yl] -4 -(2,4,5 -trifluorophenyl) butan-1 one phosphate hydrate ( Fig. 1) is oral hypoglycemic drug of the dipeptidyl peptidase-4(DPP-4) inhibitor class. DPP-4 inhibitors represent a new therapeutic approach to the treatment of type 2 diabetes that functions to stimulate glucose-dependent insulin release and reduce glucagons levels. This is done through inhibition of the inactivation of in cretins, particularly glucagonlike peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP), thereby improving glycemic control (Herman et al., 2006 , Dubal et al.,2012 , Bala SC et al., 2010 . Several analytical methods based on UV (Parag et al., 2011 , Khan et al 2011 , RP-HPLC (Ramzia et al., 2011 , Ravi et al., 2011 , LC-MS/MS (Zeng W et al.,2010 ,Wei Z et al.,2008 , Nirogi et al.,2008 was reported for the determination of sitagliptin phosphate in plasma and urine of humans, rats and dogs. 
EXPERIMENTAL

Apparatus
A Shimadzu model 1800 double beam UV-Visible spectrophotometer with spectral width of 1 nm, wavelength accuracy of ± 0.1 nm and a pair of 10 mm matched quartz cell was used to measure absorbance of all the solutions. Spectra were automatically obtained by UV-Probe system software (Ver.2.34).
Reagents and Materials
All chemicals and reagents were used of AR grade. Authentic of SPM was obtained as gift samples from MSD Pharmaceutical private Ltd. Maharashtra, India.
Solutions of drug were scanned over the range of 200-400 nm. It was observed that the drug showed considerable absorbance at 267nm, 213nm and 276nm for zero, first and second order were selected as the wavelength for detection. The spectra of SPM show in fig. 2 , 3 and 4.
Preparation of standard stock solutions
SPM was weighed (100 mg) and dissolved in 100 ml of methanol and make up the volume up to the mark with methanol, so the final concentration of solution containing 1000 µg/ml.
Preparation of working solutions
Aliquot from the stock solutions of SPM was appropriately diluted with methanol to obtain working standard.
Method Validation
The developed method was validated for its linearity, accuracy, precision and specificity. 
LOD and LOQ
The LOD and LOQ were calculated from the equations, LOD =3.3 σ/S and LOQ = 10 σ/S, where σ is the standard deviation of the lowest standard concentration and S is the slope of the standard curve. The results are shown in table 1.
Precision
The precision of the proposed method was determined by analyzing different concentrations at different time intervals on same day (Intra-day precision) and on three different days (Interday precision). The results are shown in table 2. 
Estimation of Sitagliptine from tablet.
Marketed preparation of SPM selected for the purpose of analysis. Twenty tablets were accurately weighed and powdered quantity equivalent to 100 mg of SPM was transferred in 100 ml volumetric flask and sonicated for 30 min. Then the volume was made upto the mark with methanol and the solution was filtered using Whatman filter paper no. 42 to obtain sample stock solution. 0.5 ml of filtrate was further diluted to 10 ml with same solvent and absorbance of sample was measured against blank. The amount of SPM was calculated from the calibration curve. The results of assay are shown in table 4. 
Specificity
Interference and non-interference of excipients and binders was confirmed by performing the specificity study. Specificity was performed by spiking placebo with standard drug.
RESULTS AND DISCUSSION
As shown in fig. 2 , 3, 4 SPM showed wavelength maxima at 267,213 and 276 nm in methanol. As shown in fig. 5 , 6, 7 and table 1, the calibration curves are clearly indicates linearity of developed method. Results of intra-day and inter-day precision were expressed in % RSD and found to be within the allowable limit of ≤ 2%. It clearly indicates that the developed method is precise. The % Recoveries for SPM were found to be satisfied as shown in table 3;clearly indicate that the developed method is accurate. Assay result is in good agreements with the label claim. Hence, the proposed method can be successfully used for its analysis and quality control of marketed solid dosage preparation with good linearity, accuracy and precision.
CONCLUSION
From the above results it can be concluded that, the developed method is simple, rapid, accurate, precise, specific and economical. Hence, this method can be applied for quantitative analysis of Sitagliptine in bulk and pharmaceutical formulation like tablet dosage form.
